Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0001019056-18-000786

Options or other derivatives

  • Director acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Kunz Barbara Lopez Director 2018-06-01 Grant or award · Stock Option (right to buy) +25,000 25,000 D: show line 1 in the form
Loading xslF345X03/kunz_4.xml…